DiscoverJSCAI BEATSForward Flow in Patients with Heart Failure and Functional Mitral Regurgitation: The COAPT Trial
Forward Flow in Patients with Heart Failure and Functional Mitral Regurgitation: The COAPT Trial

Forward Flow in Patients with Heart Failure and Functional Mitral Regurgitation: The COAPT Trial

Update: 2025-03-27
Share

Description

In this discussion, Suzanne Baron, MD, FSCAI, Zach Gertz, MD, Gregg W. Stone, MD, MSCAI, and Lissa Sugeng, MD, FSCAI, highlight key findings from the JSCAI article on the impact of forward flow in heart failure (HF) patients undergoing mitral transcatheter edge-to-edge repair (TEER). The panel discusses data from the COAPT trial, which stratified patients by baseline forward flow and assessed outcomes with TEER plus guideline-directed medical therapy (GDMT) versus GDMT alone. Read the article in JSCAI: https://doi.org/10.1016/j.jscai.2025.102609

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Forward Flow in Patients with Heart Failure and Functional Mitral Regurgitation: The COAPT Trial

Forward Flow in Patients with Heart Failure and Functional Mitral Regurgitation: The COAPT Trial

The Journal of the Society for Cardiovascular Angiography & Interventions